Clinical, molecular, and immunological responses to pembrolizumab treatment of synchronous melanoma and acute myeloid leukemia

Anne Sophie Kubasch; Rebekka Wehner; Serena Bazzurri; Antje Tunger; Sebastian Stasik; Marlene Garzarolli; Jörn Meinel; Gustavo Baretton; Friedegund Meier; Christian Thiede; Marc Schmitz; Uwe Platzbecker

doi:10.1182/bloodadvances.2017014811

Clinical, molecular, and immunological responses to pembrolizumab treatment of synchronous melanoma and acute myeloid leukemia

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

Anne Sophie Kubasch - , University Center for Rare Diseases, Department of internal Medicine I (Author)
Rebekka Wehner - , Institute for Immunology, University Medicine (Faculty of Medicine and University Hospital), German Cancer Consortium (Partner: DKTK, DKFZ), National Center for Tumor Diseases (Partners: UKD, MFD, HZDR, DKFZ), German Cancer Research Center (DKFZ) (Author)
Serena Bazzurri - , Santo Stefano Hospital (Author)
Antje Tunger - , Institute for Immunology, National Center for Tumor Diseases (Partners: UKD, MFD, HZDR, DKFZ) (Author)
Sebastian Stasik - , Department of internal Medicine I (Author)
Marlene Garzarolli - , Department of Dermatology (Author)
Jörn Meinel - , TUD Dresden University of Technology (Author)
Gustavo Baretton - , Institute of Pathology, German Cancer Consortium (Partner: DKTK, DKFZ), National Center for Tumor Diseases (Partners: UKD, MFD, HZDR, DKFZ), German Cancer Research Center (DKFZ) (Author)
Friedegund Meier - , Department of Dermatology, German Cancer Consortium (Partner: DKTK, DKFZ), National Center for Tumor Diseases (Partners: UKD, MFD, HZDR, DKFZ), German Cancer Research Center (DKFZ) (Author)
Christian Thiede - , German Cancer Consortium (Partner: DKTK, DKFZ), Department of internal Medicine I, TUD Dresden University of Technology, German Cancer Research Center (DKFZ) (Author)
Marc Schmitz - , Institute for Immunology, German Cancer Consortium (Partner: DKTK, DKFZ), Department of internal Medicine I, National Center for Tumor Diseases (Partners: UKD, MFD, HZDR, DKFZ), German Cancer Research Center (DKFZ) (Author)
Uwe Platzbecker - , TUD Dresden University of Technology, German Cancer Consortium (DKTK) Partner Site Dresden, German Cancer Research Center (DKFZ) (Author)

Details

Original language	English
Pages (from-to)	1187-1190
Number of pages	4
Journal	Blood advances
Volume	2
Issue number	11
Publication status	Published - 12 Jun 2018
Peer-reviewed	Yes

External IDs

PubMed	29844203
ORCID	/0000-0003-4340-9706/work/147143192

Research Portal of the TU Dresden

Clinical, molecular, and immunological responses to pembrolizumab treatment of synchronous melanoma and acute myeloid leukemia

Contributors

Details

External IDs

Keywords

ASJC Scopus subject areas

Library keywords